[Aminoglycoside antibiotics from clinical viewpoint].
Indications, side effects, dosage and several pharmacokinetic properties of gentamicin, tobramycin, sisomicin, kanamycin, amikacin, and streptomycin are delt with in the first part. Hereafter, some aspects are briefly mentioned concerning combinations of antibiotics with aminoglycosides, as well as indications for the evaluation and analysis of the aminoglycoside concentration in the serum.
D000583:Amikacin / Q000627:therapeutic use; D000617:Aminoglycosides / Q000097:blood / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000097:blood / Q000627:therapeutic use; D004338:Drug Combinations; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D004927:Escherichia coli Infections / Q000188:drug therapy; D005839:Gentamicins / Q000009:adverse effects / Q000627:therapeutic use; D005919:Glomerular Filtration Rate; D007612:Kanamycin / Q000009:adverse effects / Q000627:therapeutic use; D007710:Klebsiella Infections / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011532:Providencia; D011552:Pseudomonas Infections / Q000188:drug therapy; D012705:Serratia; D012853:Sisomicin / Q000627:therapeutic use; D013307:Streptomycin / Q000009:adverse effects / Q000627:therapeutic use; D014031:Tobramycin / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005839:Gentamicins; D007612:Kanamycin; D000583:Amikacin; D014031:Tobramycin; D012853:Sisomicin; D013307:Streptomycin
Aminoglykosid-Antibiotika aus klinischer Sicht